drugset / Trial / NCT04551768
Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is a Phase 1, open label, non-randomized, two-arm interventional clinical trial to evaluate the safety and efficacy of Virazole® in hospitalized adult patients who have tested positive for COVID-19 and, as a result, have significant respiratory distress (PaO2/FiO2 ratio \<300 mmHg).
Timeline
- Start
- 2021-02-10
- Primary completion
- 2021-08-17
- Completion
- 2021-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ribavirin | Small molecule | 50 mg/ml | Inhaled |
| Subject | Ribavirin | Small molecule | 100 mg/ml | Inhaled |